ferric citrate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4538	3522-50-7

Description:

Molecule

Description

Synonyms:

fexeric
ferric citrate hydrate
ferric citrate
ferric citrate trihydrate

Molecular weight: 244.94
Formula: C6H5FeO7
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA: 99.13
ALOGS:
ROTB: None

Drug dosage:

Dose	Unit	Route
6	g	O

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
Sept. 5, 2014	FDA	KERYX BIOPHARMS
March 23, 2021	PMDA	Japan Tobacco Inc.

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	V03AE08	VARIOUS ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS Drugs for treatment of hyperkalemia and hyperphosphatemia
CHEBI has role	CHEBI:50733	Dietary Supplement
CHEBI has role	CHEBI:75835	antianaemic drug

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Hyperphosphatemia	indication	20165001	DOID:0050459
Iron deficiency anemia	indication	87522002

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Patent number	Patent expiration date	Patent use
EQ 210MG IRON	AURYXIA	KERYX BIOPHARMS	N205874	Sept. 5, 2014	RX	TABLET	ORAL	8338642	Feb. 18, 2024	CONTROL OF SERUM PHOSPHOROUS LEVELS
EQ 210MG IRON	AURYXIA	KERYX BIOPHARMS	N205874	Sept. 5, 2014	RX	TABLET	ORAL	8846976	Feb. 18, 2024	CONTROL OF SERUM PHOSPHOROUS LEVELS
EQ 210MG IRON	AURYXIA	KERYX BIOPHARMS	N205874	Sept. 5, 2014	RX	TABLET	ORAL	8901349	Feb. 18, 2024	CONTROL OF SERUM PHOSPHOROUS LEVELS
EQ 210MG IRON	AURYXIA	KERYX BIOPHARMS	N205874	Sept. 5, 2014	RX	TABLET	ORAL	9050316	Feb. 18, 2024	CONTROL OF SERUM PHOSPHOROUS LEVELS
EQ 210MG IRON	AURYXIA	KERYX BIOPHARMS	N205874	Sept. 5, 2014	RX	TABLET	ORAL	9328133	Feb. 18, 2024	CONTROL OF SERUM PHOSPHOROUS LEVELS
EQ 210MG IRON	AURYXIA	KERYX BIOPHARMS	N205874	Sept. 5, 2014	RX	TABLET	ORAL	9757416	Feb. 18, 2024	CONTROL OF SERUM PHOSPHOROUS LEVELS
EQ 210MG IRON	AURYXIA	KERYX BIOPHARMS	N205874	Sept. 5, 2014	RX	TABLET	ORAL	8093423	April 21, 2026	CONTROL OF SERUM PHOSPHOROUS LEVELS
EQ 210MG IRON	AURYXIA	KERYX BIOPHARMS	N205874	Sept. 5, 2014	RX	TABLET	ORAL	10300039	July 21, 2030	CONTROL OF SERUM PHOSPHORUS LEVELS

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
D09993	KEGG_DRUG
4033763	VUID
N0000191091	NUI
4033763	VANDF
CHEBI:144421	CHEBI
CHEMBL3301597	ChEMBL_ID
CHEMBL3991241	ChEMBL_ID
C025314	MESH_SUPPLEMENTAL_RECORD_UI
17217-76-4	SECONDARY_CAS_RN
DB14520	DRUGBANK_ID
1594675	RXNORM
30829	MMSL
d08336	MMSL
007462	NDDF
763035003	SNOMEDCT_US
764380003	SNOMEDCT_US
C0060231	UMLSCUI
61300	PUBCHEM_CID
756B6D74H4	UNII

Pharmaceutical products:

None